Trials / Completed
CompletedNCT02089308
Nicotine Patch - Bioequivalence Study
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 74 (actual)
- Sponsor
- Pierre Fabre Medicament · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the bioequivalence of a new transdermal nicotine patch to that of a reference formulation following repeated applications
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Test treatment : V0116 transdermal patch | |
| DRUG | Reference treatment : Nicotine transdermal patch |
Timeline
- Start date
- 2014-03-01
- Primary completion
- 2014-05-01
- Completion
- 2014-05-01
- First posted
- 2014-03-17
- Last updated
- 2014-06-12
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02089308. Inclusion in this directory is not an endorsement.